Pomerantz LLP announced investigations into potential securities fraud and unlawful business practices at OSI Systems, lululemon athletica, and Ultragenyx Pharmaceutical. The investigation into OSI was triggered by the company's August 20, 2026 earnings report that missed revenue expectations due to deferred product deliveries, resulting in a 5.21% stock price decline.

Pomerantz LLP announced investigations into potential securities fraud at Ultragenyx Pharmaceutical, OSI Systems, and lululemon athletica. The investigation into Ultragenyx was triggered by the company's failure to meet primary endpoints in a Phase 3 clinical trial for apazunersen, resulting in a 44% stock price decline on September 3, 2026.

OSI Systems reported fourth quarter 2026 revenue that fell 8.5% short of analyst expectations, with sales declining 4.1% year-on-year to $484.1 million. The company attributed the shortfall to Security division delivery disruptions caused by Middle East conflicts, with approximately $50 million in planned deliveries delayed beyond the fiscal year-end. The stock fell 5.21% following the announcement. A law firm is investigating potential securities law violations.

Law firm Kirby McInerney LLP is investigating OSI Systems for potential securities fraud following the company's August 20, 2026 earnings report. OSI reported Q4 2026 revenue of $484.1 million, missing analyst expectations by 8.5% and declining 4.1% year-over-year. The company attributed the shortfall to $50 million in delayed Security division deliveries due to Middle East conflicts. OSI's stock fell 5.21% to $206.73 per share on August 21, 2026.

nVent Electric (NVT) is experiencing strong demand from AI-driven data center investments and power utilities, with expectations for data center sales to exceed $2 billion in 2026. The company is expanding capacity and seeing infrastructure grow to nearly 60% of sales. Despite trading at a premium valuation (P/E of 24.65X), analyst estimates for 2026 and 2027 EPS have been revised upward by 10.1% and 9.9% respectively, with the stock outperforming peers year-to-date.

OSI Systems stock fell 9.9% after reporting mixed Q4 earnings, beating on non-GAAP earnings ($3.78 vs. $3.77 expected) but missing significantly on sales ($484.1M vs. $529.7M expected). Full-year results showed only 3% GAAP earnings growth and 4% sales growth, resulting in a 22x P/E ratio that appears expensive for the growth rate. However, strong free cash flow of $245.3M (13.3x P/CF ratio) and management's forecast of 8% sales growth and 11% earnings growth for 2027 suggest potential value if the stock continues to decline.

The global explosive detectors market is projected to grow at a CAGR of 12.60% from 2026 to 2035, driven by rising security threats, airport infrastructure expansion, and geopolitical tensions. Handheld detectors and Ion Mobility Spectrometry technology dominate the market, while airports account for 46.25% of end-user demand. North America leads globally, with Asia-Pacific emerging as the fastest-growing region.

OSI Systems reported record revenue of $504.99 million and non-GAAP EPS of $3.24 in Q4 2025, exceeding analyst expectations. The Security division drove strong performance, while the Healthcare division remained weak. Management provided positive fiscal 2026 guidance with projected revenue growth of 5.4% to 8.0%.

Bragar Eagel & Squire, P.C. is investigating potential securities law violations and other unlawful business practices by XP Inc., Open Lending Corporation, and OSI Systems, Inc. The investigations are based on recent reports alleging issues with the companies' financial reporting and operations.

Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. (OSIS) following a short report by Culper Research that alleges the company's reported growth in Mexico revenues is 'largely an illusion' and accuses it of 'downplaying' U.S. Department of Justice investigations.

HealthEquity, Inc. reported weaker-than-expected Q4 earnings and provided weak guidance for FY2026, citing increased cyber threats and fraud attacks, causing its stock price to drop significantly.

Wolf Popper LLP is investigating potential claims on behalf of purchasers of OSI Systems, Inc. (OSIS) common stock after a short seller report alleged the company's Mexican revenues are largely an illusion and it has made misleading disclosures about DOJ investigations.